Dr Mark A Taylor, General Manager of the Oxford Biomedical Research Centre is one of three speakers at an event hosted by Oxfordshire Bioscience Network on 16 March at Milton Park Innovation Centre, Abingdon.
OBN is a not-for-profit biobusiness network which provides comprehensive support for UK bioscience business. Their activities are centred around networking, partnering,and a group purchasing scheme reducing purchasing costs of products and services for R&D companies.
The evening is designed to be a vigorous and thought provoking discussion as the speakers present three differing perspectives addressing this controversial question: who should pay for the commercialization of university and other public-funded research, and how should public funded research be commercialized?